Established in August 2023, the Bio-Innovation Unit operates within BGN to accelerate the translation of bio-related research into impactful, real-world technologies.
Working in close collaboration with BGU researchers across diverse domains—including pharmaceuticals, bio-convergence, diagnostics, medical devices, digital health, biotechnology, agri-tech, and food-tech—the unit provides dedicated professional support to advance early-stage discoveries toward commercialization.
The Bio-Innovation Unit systematically maps the university’s research capabilities, identifying high-potential projects from early ideation through pre-commercial development. It supports researchers in evaluating the commercial potential of their technologies, defining viable use cases, and outlining key milestones toward successful licensing. In parallel, the unit facilitates access to relevant internal and external funding opportunities.
By fostering interdisciplinary collaboration across biology, chemistry, physics, medicine, agriculture, computer science, and engineering, the unit enables the development of cutting-edge technologies at the convergence of disciplines—positioned for successful translation into industry.
